Use of N-acetyl-cysteine to Prevent Nephrotoxicity Associated with Iodinated Contrast Agents

Author(s): Mayank K. Mittal, Kanupriya Jain, Harsh Agrawal, Poonam Velagapudi, Sonal Dhuper, Arun Kumar

Journal Name: Current Drug Therapy

Volume 9 , Issue 2 , 2014

Become EABM
Become Reviewer
Call for Editor


Contrast induced nephropathy (CIN) is an iatrogenic form of acute kidney injury (AKI) with variable but growing prevalence secondary to increased need for contrast administration during medical investigations such as coronary angiography. The mechanism of CIN is complex and poorly understood but is believed to be secondary to renal medullary hypoxia secondary to direct tubular toxicity from the contrast media and vasoconstriction. N-acetylcysteine (NAC) an antioxidant and vasodilator, has shown promising results in early investigations but failed to demonstrate consistent results in subsequent clinical trials and their meta-analysis. In this review we aim to discuss pharmacological properties of NAC and appraise the literature regarding the use of NAC for the prevention of CIN after coronary angiography.

Keywords: Acetylcysteine/therapeutic use, angiography/adverse effects, contrast media/adverse effects, humans, kidney diseases/chemically induced, kidney diseases/prevention & control.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 16 July, 2014
Page: [104 - 110]
Pages: 7
DOI: 10.2174/1574885509666140716171925
Price: $65

Article Metrics

PDF: 24